Objectives To emphasise the importance of the General Data Protection Law (GDPL) when we use Additive Manufacturing (AM) technology in fetal medicine cases. Methods Images from 47 cases, including 5 sets of twins, were used. Scans were performed using high-resolution 3D ultrasound (3DUS). Magnetic resonance imaging (MRI) was performed on the same day as 3DUS. The AM technologies used were Ultimaker (USA), Formlabs Form 3 Plus (Somerville, MA, USA) and MediJet J5 Stratasys (USA).
